Skip to main content
. 2020 Jan 9;7(1):25–35. doi: 10.1002/ehf2.12567

Figure 4.

Figure 4

The temporal trends in pharmacological and device management of outpatients with heart failure with reduced ejection fraction in Europe. ACE‐I, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor neprilysin inhibitor; BB, beta‐blockers; CRT, cardiac resynchronization therapy; ESC‐HF‐LT, European Society of Cardiology Heart Failure Long‐Term Registry; ICD, implantable cardioverter defibrillator; MRA, mineralocorticoid receptor antagonist.